(Q38971556)

8 September 2017

title

MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression (English)

1 reference

8 September 2017

1 reference

Ruixin Li

1

1 reference

8 September 2017

Weijie Yuan

2

1 reference

8 September 2017

Wenjuan Mei

3

1 reference

8 September 2017

Keda Yang

4

1 reference

8 September 2017

Zihua Chen

5

1 reference

8 September 2017

publication date

26 July 2014

1 reference

Molecular and Cellular Biochemistry

8 September 2017

published in

1 reference

8 September 2017

volume

396

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

295-305

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-014-2164-6

8 September 2017

exact match

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

The epidemiology of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

The role of microRNAs in cancers of the upper gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Clinical significance of miR-146a in gastric cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

EphA2 overexpression promotes ovarian cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

EphA2 expression is associated with aggressive features in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Role of microRNA-26b in glioma development and its mediated regulation on EphA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Lymph nodes and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2164-6

Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25063221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-014-2164-6

1 reference

Dimensions Publication ID

8 September 2017

1052294802

0 references

1 reference